CAPRIOLI, FLAVIO ANDREA

CAPRIOLI, FLAVIO ANDREA  

Dipartimento di Fisiopatologia Medico-Chirurgica e dei Trapianti  

Mostra records
Risultati 1 - 20 di 249 (tempo di esecuzione: 0.0 secondi).
Titolo Data di pubblicazione Autori Tipo File Abstract
Dynamic profiling in inflammatory Bowel disease: A manifesto for personalized care 2026 Privitera, GiuseppeCaprioli, Flavio + Article (author) -
The assessment of multidimensional clinical, biological and patient-reported outcomes to evaluate the efficacy of add-on Lactobacillus rhamnosus GG supplementation in mild ulcerative colitis: a randomized pilot trial 2026 Noviello, DanieleCaprioli, FlavioVecchi, Maurizio + Article (author) -
Multicenter Real-World Outcomes of Risankizumab in Crohn's Disease: The RESOLVE IG-IBD Study 2026 Aloi, MarinaCaprioli, FlavioPastorelli, Luca + Article (author) -
Ustekinumab and JAK inhibitors outperform vedolizumab as second-line therapy in anti-TNF-experienced patients with ulcerative colitis 2026 Caprioli, Flavio APastorelli, LucaNoviello, Daniele + Article (author) -
Early recognition of peripheral spondyloarthritis in inflammatory bowel disease: A prospective observational study integrating detail questionnaire screening, ultrasound-based diagnosis, and gut microbiota profiling 2026 Santagata, FabrizioFerrito, MatteoFavalli, Ennio GiulioCaporali, RobertoDe Lucia, OrazioConforti, FrancescoO Sed, Nicole PiazzaSpina, LuisaCaridi, BrunaTrignani, GiorgiaIngrao, LucaVecchi, MaurizioCaprioli, Flavio + Article (author) -
The long game in ulcerative colitis: mirikizumab's four-year outcomes 2026 Noviello, DanieleCaprioli, Flavio Article (author) -
AIEC-derived LPS and Outer Membrane Vesicles differently drive the dysregulated immunological pathways linked to Crohn’s Disease 2025 IRENE DUSETTIFLAVIO CAPRIOLIPAOLO LANDINIALESSANDRA POLISSIPAOLA SPERANDEOMOIRA PARONI + Book Part (author) -
Evaluating bowel preparation tolerability in IBD: a phase 3 post-hoc comparison of mannitol and PEG-ASC 2025 Tontini, Gian EugenioCaprioli, FlavioPastorelli, LucaVecchi, Maurizio + Article (author) -
A "movement" worth making: why and how Transfusion Services can play a role in Fecal Microbiota Transplant programs 2025 Caprioli FBandera ACastaldi SVecchi MValenti L + Article (author) -
Adaptation of the European Crohn's Colitis Organisation quality of care standards to Italy: The Italian Group for the study of inflammatory bowel disease consensus 2025 Caprioli, Flavio Andrea + Article (author) -
Immunoproteasome Inhibition Positively Impacts the Gut-Muscle Axis in Duchenne Muscular Dystrophy 2025 Mostosi D.Cassani B.Caprioli F.Torrente Y. + Article (author) -
Lower Expression of SARS-CoV-2 Host Cell Entry Genes in the Intestinal Mucosa of IBD Patients With Quiescent or Mildly Active Disease 2025 Caprioli, Flavio AndreaPastorelli, Luca + Article (author) -
Liver Involvement in Celiac Disease and Immune-Mediated Diseases of the Small Bowel 2025 Caprioli, FlavioElli, Luca + Article (author) -
Sequencing JAK-inhibitors in ulcerative colitis: effectiveness and safety of switching within treatment class 2025 Caprioli, FlavioNoviello, Daniele + Article (author) -
Disease Monitoring in Inflammatory Bowel Disease Daily Clinical Practice and Impact on Treatment Decision Making: Real World Evidence From the Inflammatory Bowel Disease-PODCAST Study 2025 Caprioli, Flavio Andrea + Article (author) -
Curing inflammatory bowel diseases: breaking the barriers of current therapies- emerging strategies for a definitive treatment 2025 Noviello, DanieleVecchi, MaurizioCaprioli, Flavio + Article (author) -
Assessment of nutritional status and eating behaviours in patients with chronic inflammatory bowel disease: a pilot study 2025 Elli, LucaCostantino, AndreaCaprioli, FlavioTontini, Gian EugenioVecchi, MaurizioDoneda, LuisaRoncoroni, Leda + Article (author) -
Learning Curve in Intestinal Ultrasound: Advancing from Basic Skills to Advanced Competencies-Insights from the IUS IG-IBD Master Program 2025 Maconi, GiovanniCaprioli, Flavio + Article (author) -
Real-life effectiveness and safety of tofacitinib and vedolizumab as 2nd-line for ulcerative colitis after anti-TNFs: A multicenter cohort IGIBD study (VE2TO-UC) 2025 D. NovielloM. VecchiF. Caprioli + Article (author) -
Therapeutic adherence in inflammatory bowel disease: User guide from a multidisciplinary modified Delphi consensus 2025 Caprioli, FlavioVecchi, Maurizio + Article (author) -